Implicity ILR ECG Analyzer

by Implicity  · Based in France → — Experience the New Standard in AI Remote Cardiac Monitoring
Cardiology
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing
Regulatory Status Disclosed

Overview

The Implicity ILR ECG Analyzer is an AI-powered, cloud-based digital medical device designed to analyze electrocardiogram (ECG) data transmitted from implantable loop recorders (ILRs). The software applies advanced signal processing and machine learning algorithms to heart rhythm data to improve the accuracy of irregular heartbeat detection and reduce the volume of false-positive alerts.

This tool is specifically designed for:

  • Electrophysiologists and cardiologists managing patients with implantable cardiac monitors.
  • Clinical care teams, including cardiac nurses and technicians, who oversee remote monitoring workflows.
  • Cardiac remote monitoring clinics and independent diagnostic testing facilities (IDTFs).

The analyzer integrates directly into Implicity’s unified cardiac remote monitoring platform. In a typical clinical workflow, data transmitted from compatible Medtronic ILR models (such as Reveal LINQ, Reveal XT, and Reveal DX) is automatically processed in the cloud. The algorithm filters out non-actionable events and prioritizes true arrhythmic episodes, allowing clinical teams to focus their review on clinically relevant data without manual pre-filtering.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-Powered ILR ECG Analyzer: Reduces false positives by 79% for Medtronic ILRs while maintaining 99% sensitivity.
  • Unified Device Data: Centralizes and standardizes all cardiac implantable device data.
  • AI-Driven Alert Management: Filters alerts with FDA-cleared algorithms, highlighting clinically relevant events.
  • Smart Workflow Automation: Provides real-time access and automates billing workflows and reporting.
  • InLink: Streamlines in-clinic data workflow.
  • Patient Connectivity Management: Automated SMS to reconnect 28% of disconnected patients within two days.
  • AF Alert Management: Detects clinically relevant events, leading to an 85% decrease in unnecessary AF alerts.
  • Dynamic Billing Engine: Achieves 90%+ billing compliance with optimized scheduling and auto-generated reports.
  • SignalHF Predictive AI: FDA-cleared AI to predict hospitalizations for heart failure patients.
  • EHR Integration Capabilities: Comprehensive API and integration framework for seamless data exchange.

Use Cases

  • Improving arrhythmia detection for electrophysiology teams
  • Reducing false alerts and alarm fatigue for care teams
  • Automating billing and reporting for administrative and billing teams
  • Ensuring data security and compliance for IT teams
  • Optimizing remote monitoring of CIEDs and ILRs
  • Predicting hospitalizations for heart failure patients

What Physicians Need to Know

ECG/EKG Analysis Capability
The Implicity ILR ECG Analyzer provides AI-powered ECG signal processing and analysis specifically for Insertable Cardiac Monitor (ICM) data. It detects various arrhythmias including asystole, bradycardia, atrial tachycardia, atrial fibrillation, ventricular tachycardia, normal rhythm, and artifacts.
Arrhythmia Detection Accuracy
The FDA-cleared algorithm significantly reduces false positives by up to 79% in ECG recordings from Medtronic ILRs, while maintaining a high sensitivity of 99% (or >98%).
Heart Failure Risk Prediction
While the ILR ECG Analyzer focuses on arrhythmias, the broader Implicity platform includes 'SignalHF Predictive AI,' an FDA-cleared algorithm that analyzes physiological data from various CIEDs (pacemakers, ICDs, CRTs) to predict the risk of heart failure hospitalizations within 30 days.
Cardiac Monitoring Integration
The ILR ECG Analyzer is designed to interface with compatible remote monitoring platforms, specifically receiving data from Medtronic ICMs (LNQ11, REVEAL XT 9529, REVEAL DX 9528). The overarching Implicity platform is universal, aggregating and standardizing data from all major CIED manufacturers (Medtronic, Abbott, Boston Scientific, Biotronik, MicroPort) and integrating with over 80 Electronic Health Record (EHR) platforms.
AHA/ACC Guideline Alignment
The Implicity platform aligns with the 2015 HRS Expert Consensus on remote monitoring of CIEDs as the standard of care. Its AI algorithm utilizes a standardized, guideline-based framework for analyzing ICM transmissions, aiming to provide clinically actionable data.
Real-Time Alert Capability
The ILR ECG Analyzer helps prioritize true arrhythmic events, reducing the burden of false-positive alerts. The platform also features 'AF Alert Management,' which decreases unnecessary AF alerts by 85%, and the SignalHF algorithm provides automatic alerts for high heart failure hospitalization risk.
Physician Tip

The Implicity ILR ECG Analyzer serves as an advisory tool, not a standalone diagnostic. Physicians should integrate its AI-driven insights with their clinical expertise, patient history, and other diagnostic information. Leveraging this tool can significantly reduce the workload associated with false-positive alerts from ILRs, enabling more efficient patient monitoring and allowing clinicians to focus on truly actionable events and manage a larger patient cohort. The platform's ability to unify data from various device manufacturers streamlines the review process, enhancing overall workflow efficiency and potentially leading to earlier detection and intervention for critical cardiac conditions.

The Implicity ILR ECG Analyzer is specifically compatible with Medtronic Insertable Cardiac Monitors (LNQ11, REVEAL XT 9529, REVEAL DX 9528). The broader Implicity remote monitoring platform offers universal compatibility, integrating and standardizing data from all major Cardiac Implantable Electronic Device (CIED) manufacturers, including Medtronic, Abbott, Boston Scientific, Biotronik, and MicroPort. Furthermore, the platform supports integration with over 80 Electronic Health Record (EHR) systems, facilitating a comprehensive and streamlined data workflow within clinical practices.

Details

Category Cardiology AI, Wearables & Remote Monitoring (RPM)
Pricing Contact for pricing
DeploymentCloud-based SaaS
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

The Implicity ILR ECG Analyzer (IM007) is an FDA-cleared Class II medical device. SignalHF, another Implicity product, is also an FDA-cleared Class II medical device.
Integrations
EHR Not specified
Specialties Cardiology

What the Web Says

The Implicity ILR ECG Analyzer is an FDA-cleared, AI-powered algorithm designed to significantly reduce false-positive alerts from Implantable Loop Recorders (ILRs) while maintaining high sensitivity for detecting clinically relevant arrhythmias. It integrates with Implicity's universal remote cardiac monitoring platform, aiming to streamline workflows for healthcare professionals and improve patient outcomes. The system is compatible with various Medtronic ILR models, and a newer version is designed to be agnostic across multiple manufacturers.

Overall: Positive

Strengths

  • Reduces false positives by up to 79%, significantly decreasing the workload for clinicians and reducing alert fatigue.
  • Maintains high sensitivity (98-99%) in detecting true arrhythmias, ensuring patient safety.
  • FDA cleared, providing clinical confidence and regulatory assurance.
  • Universal platform consolidates data from multiple device manufacturers into one interface, simplifying clinical review.
  • Improves workflow efficiency and allows healthcare professionals to focus on critical patient management.
  • Associated with improved patient outcomes, including a reported 26% reduced mortality and 4% reduction in hospitalization length compared to conventional remote monitoring.

Limitations

  • The initial version of the ILR ECG Analyzer only supported ECG data from Medtronic ILRs.
  • Some studies indicate that even with manufacturer AI filtering, residual false positives remain, requiring a second layer of analysis like Implicity's.
  • The newer, agnostic version of the ILR ECG Analyzer is not yet FDA cleared.
  • ILR interpretation results are not intended to be the sole means of diagnosis and should be used in conjunction with a physician's knowledge and other clinical information.
  • The management of ILR transmissions can still be time-consuming, even with AI, compared to other cardiac devices.

Based on reviews from: Implicity.com, GlobeNewswire, DAIC, BioWorld, PR Newswire, Journal of Innovation in Cardiac Rhythm Management, PMC, Reddit, MDPI

Last updated: 2026-07-18

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Implicity ILR ECG Analyzer

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

PR Newswire
Implicity Receives FDA Clearance for AI-Powered ECG Analyzer for Implantable Loop Recorders
Implicity announced FDA clearance for its AI-powered ILR ECG Analyzer, a medical algorithm that analyzes ECG data from Implantable Loop Recorders (ILRs), aiming to reduce false positives and improve arrhythmia detection. The company plans to launch the algorithm in the U.S. and Europe, expanding its presence in the U.S. market.
2021-12
BioWorld
Implicity gets FDA nod for AI-powered heart rhythm analyzer | BioWorld
French startup Implicity SAS received FDA clearance for its ILR ECG Analyzer, an AI-powered algorithm designed to analyze ECG data from implantable loop recorders (ILRs) and reduce false positive alerts for atrial fibrillation and other arrhythmias. The algorithm, also CE marked, is based on 20 years of data from 3.8 million heart disease patients.
2021-12
HCPLive
Implicity's ILR ECG Analyzer Receives 510(k) Clearance from FDA | HCPLive
Implicity's ILR ECG Analyzer received 510(k) clearance from the FDA, a novel medical algorithm compatible with various Medtronic ILRs that uses AI to improve the accuracy of irregular heartbeat detection and prioritize true events. This aims to alleviate the burden on clinicians caused by excessive false positives from ILRs.
2021-12
PMC (PubMed Central)
Improved diagnostic performance of insertable cardiac monitors by an artificial intelligence-based algorithm - PMC
A study published in the European Heart Journal demonstrated that Implicity's ILR-ECG Analyzer machine learning algorithm significantly reduced the number of false-positive episodes from Implantable Cardiac Monitors (ICMs) while maintaining high sensitivity. The algorithm is both CE marked and FDA cleared.
2024-01
MD+DI
Implicity Uses AI to Cut Through False Positive ILR Noise
Implicity has received FDA clearance for a medical algorithm that uses AI to analyze ECG data from Medtronic's Implantable Loop Recorder (ILR) technology, aiming to reduce false positives and clinician workload. Unlike Medtronic's own AI algorithm, Implicity's solution is compatible with a wider range of Medtronic ILR models.
2022-02
PR Newswire
IMPLICITYu00ae to Showcase New Artificial Intelligence-based Innovations in Remote Cardiac Monitoring at HRS 2022
Implicity announced it would showcase its AI-powered ILR ECG Analyzer and other innovations in remote cardiac monitoring at the Heart Rhythm 2022 (HRS 2022) event, following its FDA clearance in December 2021. The company aims to highlight the impact of AI in managing ILR dataflows and transforming remote cardiac monitoring.
2022-04
GlobeNewswire
Study Shows Implicity's New Agnostic Cloud-Based AI Algorithm Further Reduces False Alerts Even After Manufacturer AI Filtering in Modern Devices - GlobeNewswire
Implicity presented new findings at HRS 2026, demonstrating that its next-generation ILR ECG Analyzer, an agnostic cloud-based AI algorithm, can significantly reduce residual false-positive alerts even in AI-equipped devices. The study showed a 61.6% reclassification of false-positive alerts while maintaining 98.3% sensitivity.
2026-04
Implicity
EHRA 2026 Studies Reveal Why False Positives Persist in AI-Equipped Implantable Cardiac Monitors - Implicity
New research presented at the 2026 European Heart Rhythm Association Congress (EHRA) by Implicity explored the persistence of false-positive alerts in implantable cardiac monitors, even with manufacturer AI. The study highlighted how Implicity's cloud-based ILR ECG Analyzer can maintain high sensitivity for clinically meaningful arrhythmias while filtering non-actionable alerts.
2026-04

Videos

Product demos, reviews, and walkthroughs for Implicity ILR ECG Analyzer.

View all on YouTube

Frequently Asked Questions

The Implicity ILR ECG Analyzer is an AI-powered algorithm designed to analyze ECG data from Implantable Loop Recorders (ILRs). Its main clinical benefit is significantly reducing false-positive arrhythmia detections, particularly atrial fibrillation, which decreases the manual review workload for electrophysiologists and their teams. This allows healthcare professionals to focus more efficiently on clinically actionable events and improve patient management.
Yes, the Implicity ILR ECG Analyzer has received FDA 510(k) clearance as a Class II medical device in the United States. It is also CE marked as a Class I medical device under the Medical Device Directive 93/42 in Europe. Implicity also implements technical and organizational measures to ensure data privacy and security, aligning with relevant data protection laws.
The Implicity ILR ECG Analyzer differentiates itself by being compatible with several previous Medtronic ILR models (Reveal LINQ, Reveal XT, and Reveal DX), unlike Medtronic's own AI which is specific to LINQ II. While other AI ECG analysis tools and traditional methods exist, Implicity's algorithm has demonstrated a significant reduction in false positives (79%) while maintaining high sensitivity (99%) in clinical studies.
The Implicity ILR ECG Analyzer is intended as an advisory tool for qualified healthcare professionals and should not be used as the sole means of diagnosis. It is not designed for life-supporting or sustaining systems or ECG monitor and alarm devices. While it significantly reduces false positives, it does not eliminate them entirely, and clinicians must still apply their judgment in conjunction with patient history and other diagnostic information.
Implicity states it applies technical and organizational measures to ensure an appropriate level of security for personal data processing, aiming to prevent loss, misuse, and unauthorized access or disclosure. They also have safeguards in place for data transfers outside the European Union, such as Standard Contractual Clauses, and do not transfer personal health data to third countries outside the European Economic Area.
The Implicity ILR ECG Analyzer is specifically compatible with ECG data from Medtronic Implantable Loop Recorders, including the Reveal LINQ, Reveal XT, and Reveal DX models. This allows for enhanced analysis of data from a widely implanted base of devices.
Specific pricing or cost models for the Implicity ILR ECG Analyzer are not publicly disclosed in the provided search results. Typically, such information is obtained directly from Implicity through a sales inquiry or demonstration, as pricing often depends on factors like practice size, volume of patients, and integration requirements.

Compare Implicity ILR ECG Analyzer

VS
BrightHeart View Classifier vs Implicity ILR ECG Analyzer
Cardiology AI Adjacent · 65/100
BrightHeart View Classifier focuses on AI-powered guidance and analysis for *prenatal ultrasound exams* to detect congenital heart defects and ensure exam completeness. Implicity ILR ECG Analyzer, on the…
VS
Implicity ILR ECG Analyzer vs PMcardio
Cardiology AI Adjacent · 65/100
Tool A, Implicity ILR ECG Analyzer, focuses on remote monitoring of cardiac implantable devices and ILRs, aiming to reduce false positives and streamline workflows for existing device data.…
VS
Implicity ILR ECG Analyzer vs EchoNext
Cardiology AI Adjacent · 65/100
These tools are adjacent in their application of AI to cardiology but serve different primary functions. Implicity ILR ECG Analyzer focuses on optimizing remote monitoring and management of…
VS
Implicity ILR ECG Analyzer vs Cardiomo
Cardiology AI Adjacent · 65/100
These tools are adjacent in their comparability, both focusing on AI-powered remote cardiac monitoring. Implicity ILR ECG Analyzer specializes in optimizing workflows and reducing false positives for existing…

Related Tools

Cardiomatics
Cardiomatics
Cardiology AI
Cardiomatics is a cloud-based, AI-powered software for analyzing ambulatory (Holter) ECG tests, using clinically validated algorithms to provide accurate and high-quality results for cardiac diagnostics. It aims to streamline ECG analysis, reduce interpretation time, and improve diagnostic accuracy for various heart conditions.
Paid, credit-based or subscription
SafeBeat Rx App
SafeBeat Rx, Inc.
Cardiology AI
An AI application designed to support safe pharmacological treatment and monitoring for cardiac arrhythmias.
PreemptiveAI Clinical SDK
Measure Labs, Inc. (Dba Preemptiveai, Inc.)
Cardiology AI
A clinical software development kit using AI to model and predict cardiovascular health metrics, aiming to shift healthcare from reactive to proactive by providing early health risk signals.
Clarius Ejection Fraction AI
Clarius Mobile Health Corp.
Cardiology AI
Clarius Ejection Fraction AI is an AI-powered ultrasound tool for automated left ventricular ejection fraction calculation, integrated into the Clarius Ultrasound App for real-time cardiac assessments.
Contact for pricing
Automated Aortic Stenosis Software (AutoAS)
Multiple companies are developing Automated Aortic Stenosis Software (AutoAS) or similar AI-powered solutions. Notable ones include iCardio.ai, Us2.ai, AccurKardia, HeartSciences Inc., and Echo IQ.
Cardiology AI
Automated Aortic Stenosis Software (AutoAS) is an ultrasound application by GE Medical Systems that provides automated assessment of aortic stenosis to enhance diagnostic efficiency and consistency.
ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm
Anumana
Cardiology AI
An AI algorithm that analyzes standard 12-lead ECG recordings to detect signs of pulmonary hypertension, aiming for earlier diagnosis and improved patient outcomes.

See all Cardiology AI tools →

More from Implicity

IM007
Implicity
Cardiology AI
Implicity offers an FDA-cleared, AI-powered, cloud-based platform for remote cardiac monitoring. It aggregates data from all cardiac implantable electronic devices (CIEDs) to streamline workflows, reduce false alerts, and improve patient outcomes in cardiology and heart failure management. Note: This tool is a remote cardiac monitoring platform, not a physician directory.
Contact for pricing
SignalHF
Implicity
Cardiology AI
SignalHF by Implicity is an FDA-cleared AI algorithm that predicts heart failure hospitalizations within 30 days by analyzing data from various cardiac implantable electronic devices, enabling early intervention and personalized care.
Contact for pricing

View company profile →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18

Investors who backed Implicity ILR ECG Analyzer

Funded through the company that built this tool.

Serena
VC T3
Paris, France
$1M-$5M
Serena is a Paris-based generalist venture firm investing across consumer technology, B2B software, fintech, and selectively in health technology, with a portfolio…
AI/ML in Healthcare Care Delivery / Tech-Enabled Services
AI Tool Finder
AI-powered search. Results may not be comprehensive.